An Ningfei, Kang Yubin
Division of Hematology-oncology, Department of Medicine, Medical University of South Carolina, USA.
J Vis Exp. 2013 Mar 7(73):e50193. doi: 10.3791/50193.
Murine bone marrow transplantation models provide an important tool in measuring hematopoietic stem cell (HSC) functions and determining genes/molecules that regulate HSCs. In these transplant model systems, the function of HSCs is determined by the ability of these cells to engraft and reconstitute lethally irradiated recipient mice. Commonly, the donor cell contribution/engraftment is measured by antibodies to donor- specific cell surface proteins using flow cytometry. However, this method heavily depends on the specificity and the ability of the cell surface marker to differentiate donor-derived cells from recipient-originated cells, which may not be available for all mouse strains. Considering the various backgrounds of genetically modified mouse strains in the market, this cell surface/ flow cytometry-based method has significant limitations especially in mouse strains that lack well-defined surface markers to separate donor cells from congenic recipient cells. Here, we reported a PCR-based technique to determine donor cell engraftment/contribution in transplant recipient mice. We transplanted male donor bone marrow HSCs to lethally irradiated congenic female mice. Peripheral blood samples were collected at different time points post transplantation. Bone marrow samples were obtained at the end of the experiments. Genomic DNA was isolated and the Y chromosome specific gene, Zfy1, was amplified using quantitative Real time PCR. The engraftment of male donor-derived cells in the female recipient mice was calculated against standard curve with known percentage of male vs. female DNAs. Bcl2 was used as a reference gene to normalize the total DNA amount. Our data suggested that this approach reliably determines donor cell engraftment and provides a useful, yet simple method in measuring hematopoietic cell reconstitution in murine bone marrow transplantation models. Our method can be routinely performed in most laboratories because no costly equipment such as flow cytometry is required.
小鼠骨髓移植模型为衡量造血干细胞(HSC)功能以及确定调控造血干细胞的基因/分子提供了重要工具。在这些移植模型系统中,造血干细胞的功能由这些细胞植入并重建经致死性照射的受体小鼠的能力来决定。通常,通过使用流式细胞术针对供体特异性细胞表面蛋白的抗体来测量供体细胞的贡献/植入情况。然而,该方法严重依赖于细胞表面标志物区分供体来源细胞与受体来源细胞的特异性和能力,而这并非对所有小鼠品系都可行。考虑到市场上基因改造小鼠品系的各种背景,这种基于细胞表面/流式细胞术的方法存在显著局限性,尤其是在缺乏明确表面标志物以区分供体细胞与同基因受体细胞的小鼠品系中。在此,我们报道了一种基于PCR的技术来确定移植受体小鼠中供体细胞的植入/贡献情况。我们将雄性供体骨髓造血干细胞移植到经致死性照射的同基因雌性小鼠体内。在移植后的不同时间点采集外周血样本。在实验结束时获取骨髓样本。分离基因组DNA,并使用定量实时PCR扩增Y染色体特异性基因Zfy1。根据已知比例的雄性与雌性DNA的标准曲线计算雌性受体小鼠中雄性供体来源细胞的植入情况。使用Bcl2作为参照基因来标准化总DNA量。我们的数据表明,这种方法能够可靠地确定供体细胞的植入情况,并为测量小鼠骨髓移植模型中的造血细胞重建提供了一种有用且简便的方法。我们的方法在大多数实验室都可常规进行,因为无需诸如流式细胞仪等昂贵设备。